Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:41 PM
NCT ID: NCT05393869
Description: None
Frequency Threshold: 0
Time Frame: 1 hour post-baseline
Study: NCT05393869
Study Brief: Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AR-Quit Participants view messages with absolute risk and quit statements Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
AR-Switch Participants view messages with absolute risk and switch statements Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
AR-Combination Participants view messages with absolute risk and combination quit+switch statements Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
RR-Quit Participants view messages with comparative risk and quit statements Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
RR-Switch Participants view messages with comparative risk and switch statements Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
RR-Combination Participants view messages with comparative risk and combination quit+switch statements Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
Control Participants view FDA regulatory messages Health communications: Participants are assigned to view health communications with risk and efficacy statements. 0 None 0 407 0 407 View
Serious Events(If Any):
Other Events(If Any):